genia tagger: 205('stains', 4)
('laminin-5', 1)
('lymph', 25)
('c-terminal', 2)
('no\\.', 2)
('human', 5)
('expression\\.', 6)
('myoepithelial', 10)
('ssps', 2)
('heterodimer', 1)
('24', 11)
('25', 13)
('26', 22)
('27', 6)
('20', 40)
('21', 18)
('22', 6)
('23', 17)
('\\>', 10)
('\\?', 407)
('\\:', 10)
('29', 12)
('guanine', 5)
('0', 471)
('only', 21)
('other', 12)
('black', 2)
('4', 344)
('factor', 23)
('\\.', 492)
('8', 91)
('nodes', 10)
('\\*', 20)
('\\(', 198)
('\\)', 198)
('11', 11)
('lrf', 4)
('metastasis\\.', 8)
('2\\.1\\-3\\.0', 2)
('12', 19)
('breast', 53)
('1b', 2)
('net1', 124)
('axillary', 6)
('ductal', 12)
('pbs', 6)
('55', 12)
('54', 2)
('antihuman', 2)
('3\\.1\\-4\\.0', 2)
('proteins', 4)
('50', 8)
('progesterone', 8)
('p', 1029)
('vector', 6)
('mrna', 2)
('4-9', 2)
('small', 3)
('64', 4)
('signal', 21)
('rhoa-specific', 3)
('56', 4)
('luminal', 4)
('her2\\.', 2)
('36-50', 2)
('bovine', 4)
('growth', 5)
('her2', 72)
('439-9b', 2)
('52', 4)
('absent', 6)
('factors', 13)
('nuclear', 22)
('localization', 4)
('unknown', 4)
('cell', 40)
('3', 241)
('51-70', 2)
('7', 99)
('integrin\xe2\x80\x93rhoa', 6)
('isoforms', 1)
('signaling-deficient', 2)
('exchange', 5)
('genes', 12)
('histologic', 4)
('standard', 4)
('labs', 6)
('fig\\.', 12)
('rhoa', 24)
('anti-net1', 4)
('38', 6)
('g', 652)
('3\\+', 10)
('33', 8)
('many', 5)
('30', 31)
('37', 6)
('36', 8)
('35', 19)
('spss', 2)
('tumor', 80)
('laminin', 2)
('neuroepithelioma', 2)
('gene', 35)
('antibody', 10)
('family', 4)
('grade', 18)
('invasive', 30)
('70', 8)
('avidin-biotin', 2)
('receptor', 43)
('65', 4)
('66', 2)
('sequences', 2)
('marker', 8)
('table', 18)
('post', 2)
('amino', 4)
('pr', 249)
('type', 8)
('positive', 74)
('abbreviations', 2)
('42', 8)
('negative', 32)
('lobular', 8)
('1a', 2)
('4\\.1\\-5\\.0', 2)
('2', 365)
('integrin', 62)
('6', 289)
('white', 2)
('albumin', 4)
('was', 138)
('monoclonal', 2)
('integrins', 2)
('1\\.1\\-2\\.0', 2)
('lymphovascular', 11)
('alone\\.', 7)
('menopausal', 2)
('39', 12)
('rabbit', 4)
('particular', 2)
('\\,', 330)
('present', 6)
('epidermal', 3)
('10', 41)
('13', 11)
('terminus', 2)
('15', 20)
('14', 17)
('17', 5)
('16', 13)
('19', 14)
('18', 10)
('cells', 20)
('cytoplasmic', 28)
('2\\+', 10)
('32', 10)
('metastases', 4)
('epithelial', 13)
('pre', 174)
('estrogen', 20)
('5\\.0', 4)
('12\\.0', 2)
('rat', 49)
('eighteen', 2)
('ras', 7)
('protein', 13)
('34', 12)
('serum', 16)
('1-3', 6)
('l\\/ml', 2)
('81', 2)
('48', 14)
('hispanic', 8)
('47', 10)
('-', 172)
('43', 4)
('40', 12)
('41', 8)
('1', 475)
('trastuzamab', 2)
('5', 184)
('9', 131)
('peroxidase', 6)
('subunit', 15)
('node', 19)
('multiple', 7)
('normal', 14)
('transforming', 2)
('clone', 2)
('carcinoma', 23)
('rho', 25)
('immunohistochemical', 12)
('nucleotide', 5)
('net1\\.', 8)
('51', 4)
('surrogate', 2)
('gtpases', 1)
('acids', 2)
('polyclonal', 2)
('immunoperoxidase', 2)
('n1', 2)
('20-35', 2)
('er', 527)


spacy + metamap: 461('concept', 2)
('tamoxifen', 8)
('lack', 6)
('four', 10)
('data sets', 2)
('tx', 2)
('laminin', 2)
('young', 2)
('mediated', 5)
('nodes', 10)
('mammary gland', 2)
('nuclear localization signal', 2)
('risk', 5)
('activation', 8)
('difference', 2)
('categories', 2)
('entire', 4)
('\\%\\ positive', 4)
('pbs', 6)
('level', 4)
('deficient', 2)
('vector', 6)
('relation', 2)
('mrna expression', 2)
('force', 2)
('findings', 3)
('trend', 2)
('antigen', 5)
('estimates', 4)
('patient', 100)
('abc', 2)
('section', 7)
('lymphovascular invasion', 11)
('ssps', 2)
('cell', 40)
('tissue microarray', 11)
('neu', 4)
('peroxidase activity', 2)
('method', 10)
('contrast', 2)
('genes', 12)
('component', 1)
('triple-negative breast cancers', 2)
('myosin', 2)
('groups', 2)
('paraffin', 9)
('strong', 6)
('cell motility', 2)
('contraction', 2)
('institutional review board', 2)
('thirty', 2)
('study', 32)
('gene', 35)
('changes', 2)
('diameter', 2)
('useful', 1)
('family', 4)
('invasive breast carcinomas', 4)
('ninety', 4)
('decrease', 22)
('marker', 8)
('total', 5)
('post', 2)
('positive', 74)
('abbreviations', 2)
('faint', 2)
('two', 10)
('few', 4)
('criteria', 6)
('0\\%', 28)
('biotin', 6)
('rabbit', 4)
('cases', 4)
('ml', 6)
('modified', 3)
('eighteen', 2)
('values', 4)
('metastases', 4)
('10\\%', 6)
('control', 15)
('sps', 4)
('cancer center', 4)
('high', 9)
('serum', 16)
('dialysis', 2)
('discussion', 2)
('six', 4)
('feature', 6)
('methanol', 2)
('significance', 4)
('goat', 6)
('30 min', 2)
('profile', 2)
('blocks', 2)
('prognostic', 4)
('in vitro', 2)
('eighty', 2)
('tumor recurrence', 2)
('invasion', 13)
('data', 16)
('short', 4)
('biomarker', 1)
('room temperature', 6)
('univariate analysis', 8)
('mastectomy', 3)
('retrieval', 5)
('1a', 2)
('preclinical', 2)
('primary tumors', 2)
('report', 8)
('staining', 56)
('unknown', 4)
('group', 13)
('h2o2', 2)
('23', 17)
('alternative therapies', 2)
('edge', 6)
('better', 2)
('window', 2)
('lu', 85)
('fig', 20)
('decreased', 19)
('texas', 2)
('ym', 27)
('greater', 3)
('signaling pathway', 6)
('number', 6)
('lymph node metastases', 4)
('hormone receptor', 11)
('net1', 124)
('histologic type', 4)
('several', 2)
('university', 2)
('l-', 8)
('proteins', 4)
('pathway', 8)
('bursts', 2)
('mean', 8)
('subset', 5)
('protein a-sepharose', 2)
('conflicting', 2)
('generation', 2)
('series', 2)
('year', 17)
('methotrexate', 6)
('laboratory', 2)
('human epidermal growth factor receptor', 3)
('er', 527)
('negative control', 8)
('breast tissue', 8)
('20\\%', 10)
('forty', 2)
('adhesion', 2)
('race', 10)
('induced', 1)
('evaluation', 4)
('immunohistochemistry', 5)
('1\\+', 2)
('free', 30)
('standard', 4)
('labs', 6)
('difficulty', 4)
('biological', 2)
('rhoa', 24)
('log', 26)
('rearrangements', 2)
('cycles', 14)
('filter', 2)
('signature', 2)
('first', 2)
('initial', 2)
('grade', 18)
('variables', 5)
('primary', 12)
('rank', 4)
('one', 49)
('randomized', 4)
('cytoskeletal', 4)
('array', 13)
('background stain', 2)
('node-positive', 3)
('ten', 4)
('lymph nodes', 8)
('introduction', 1)
('leading', 2)
('top', 32)
('plastic', 2)
('traction', 4)
('motility', 4)
('inclusion criteria', 2)
('chemotherapy', 6)
('percentage', 2)
('final', 2)
('integrins', 2)
('slides', 4)
('part', 6)
('signaling', 18)
('authors', 2)
('white', 2)
('population', 2)
('cell nucleus', 2)
('patients', 84)
('individual', 7)
('outcome', 19)
('result', 15)
('myoepithelial cell', 8)
('cytoplasm', 30)
('vinblastine', 6)
('rat', 49)
('30\\%', 2)
('her2', 72)
('concentration', 4)
('m\\.d\\.', 4)
('mechanism', 2)
('guanine nucleotide exchange factor', 5)
('resectable', 2)
('forces', 2)
('objective', 2)
('peroxidase', 6)
('multiple', 7)
('normal', 14)
('carcinoma', 23)
('71', 4)
('preliminary', 2)
('future', 2)
('basal', 10)
('windows', 2)
('average', 4)
('protein expression', 2)
('disease', 5)
('subgroup', 4)
('invasive breast carcinoma', 10)
('aggressive', 1)
('papillary', 2)
('availability', 2)
('current', 4)
('indicator', 2)
('based', 8)
('knowledge', 4)
('retrospective study', 6)
('proportion', 6)
('terminal', 2)
('only', 21)
('actin', 2)
('factor', 23)
('\\/ml', 6)
('normal breast', 10)
('mixture', 2)
('overall', 27)
('ssp', 2)
('greater than', 2)
('axillary lymph node', 2)
('breast', 53)
('bead', 2)
('years', 7)
('secondary', 4)
('distant metastasis', 36)
('beads', 2)
('tumors', 19)
('median', 1)
('subtype', 4)
('activity', 4)
('fixed', 1)
('irradiation', 2)
('set', 13)
('immunoperoxidase', 2)
('detection', 2)
('cytoplasmic', 28)
('migration', 5)
('estrogen receptor', 20)
('surgery', 2)
('nuclear', 22)
('state', 3)
('score', 10)
('therapies', 8)
('available', 4)
('high risk', 3)
('ability', 3)
('targeted', 4)
('weak', 2)
('hypothesis', 6)
('improved', 2)
('3\\+', 10)
('patient outcome', 4)
('heating', 2)
('expression', 125)
('cancer', 33)
('tumor cell migration', 4)
('reasons', 2)
('invasive', 30)
('period', 2)
('sequences', 2)
('table', 18)
('pr', 249)
('progesterone receptor', 8)
('addition', 6)
('three', 2)
('lobular', 8)
('integrin', 62)
('treatment', 6)
('sufficient', 6)
('value', 6)
('1 h', 10)
('2\\+', 10)
('inverse association', 2)
('formalin', 1)
('layer', 8)
('membranous', 10)
('characteristics', 2)
('tissue', 29)
('tumor cell', 20)
('triple', 6)
('tumorigenesis', 4)
('protein', 13)
('regression', 6)
('cohort', 10)
('radiation', 3)
('member', 3)
('microarray', 11)
('subunit', 15)
('higher', 2)
('development', 5)
('independent', 13)
('total mastectomy', 1)
('1-2', 2)
('kit', 2)
('immunohistochemical', 12)
('recent', 3)
('antibodies', 2)
('center', 4)
('studies', 4)
('analysis', 35)
('hispanic', 8)
('materials', 1)
('entry', 2)
('model', 8)
('usual', 2)
('citrate buffer', 4)
('abbreviation', 4)
('50\\%', 2)
('intervals', 2)
('distant', 38)
('breast cancers', 12)
('aspect', 4)
('purified', 4)
('myoepithelial', 10)
('previous', 4)
('tables', 2)
('association', 44)
('associations', 7)
('bovine serum albumin', 4)
('increased', 4)
('survival', 52)
('early', 4)
('finding', 5)
('ducts', 2)
('background', 6)
('axillary', 6)
('outcome measure', 2)
('ductal', 12)
('55', 12)
('manual', 2)
('specific', 6)
('benefit', 2)
('either', 3)
('dilution', 2)
('transforming gene', 2)
('satisfactory', 2)
('methods', 1)
('luminal', 4)
('kda', 2)
('export', 4)
('69', 2)
('subtypes', 2)
('invasive lobular carcinoma', 4)
('ductal epithelium', 2)
('invasive lobular carcinomas', 2)
('microwave', 4)
('moderate', 4)
('gene expression', 4)
('bd', 2)
('core', 20)
('data analysis', 2)
('surgical treatment', 2)
('power', 2)
('axillary dissection', 4)
('pressure', 2)
('step', 2)
('glycerol', 4)
('g\\/ml', 4)
('column', 2)
('months', 4)
('statistically significant', 2)
('positive lymph node', 6)
('tumor', 80)
('range', 12)
('plus', 6)
('mixed', 2)
('insufficient', 4)
('neuroepithelioma', 2)
('antibody', 10)
('block', 4)
('significant', 19)
('presence', 2)
('instruments', 2)
('scores', 2)
('cyclophosphamide', 8)
('functional', 2)
('negative', 32)
('receptor', 43)
('surrogate marker', 2)
('multivariate analysis', 13)
('additional', 4)
('sequence', 2)
('long', 3)
('immunohistochemical stains', 4)
('clinical', 18)
('low', 16)
('gene transcription', 2)
('breast cancer', 25)
('function', 4)
('70\\%', 4)
('mice', 6)
('absent', 6)
('cells', 20)
('doxorubicin', 14)
('cancers', 16)
('mouse model', 2)
('problem', 2)
('similar', 2)
('breast ducts', 2)
('estrogen', 20)
('regression analysis', 2)
('receptor expression', 2)
('tissues', 3)
('metastasis', 40)
('al', 434)
('single', 2)
('epithelial', 13)
('follow-up', 4)
('ductal epithelial cell', 2)
('functions', 1)
('invasive growth', 2)
('role', 6)
('cell adhesion', 2)
('meaning', 2)
('important', 16)
('nucleus', 6)
('n1', 2)
('variable', 11)
('homolog', 3)
('hazard ratio', 12)
('cooker', 2)
('exact test', 4)
('age', 24)
('molecular profiling', 2)
('curve', 4)
('diagnosis', 4)
('avidin', 2)
('n2', 2)
('original', 2)


total: 598('concept', 2)
('laminin-5', 1)
('tamoxifen', 8)
('lack', 6)
('four', 10)
('data sets', 2)
('tx', 2)
('laminin', 2)
('young', 2)
('0', 471)
('nodes', 10)
('mammary gland', 2)
('nuclear localization signal', 2)
('risk', 5)
('lrf', 4)
('activation', 8)
('difference', 2)
('categories', 2)
('entire', 4)
('\\%\\ positive', 4)
('pbs', 6)
('level', 4)
('deficient', 2)
('progesterone', 8)
('p', 1029)
('vector', 6)
('scores', 2)
('small', 3)
('relation', 2)
('mrna expression', 2)
('force', 2)
('findings', 3)
('trend', 2)
('antigen', 5)
('36-50', 2)
('estimates', 4)
('her2', 72)
('439-9b', 2)
('abc', 2)
('section', 7)
('lymphovascular invasion', 11)
('availability', 2)
('cell', 40)
('tissue microarray', 11)
('neu', 4)
('isoforms', 1)
('method', 10)
('contrast', 2)
('exchange', 5)
('genes', 12)
('component', 1)
('triple-negative breast cancers', 2)
('myosin', 2)
('groups', 2)
('paraffin', 9)
('strong', 6)
('cell motility', 2)
('contraction', 2)
('institutional review board', 2)
('39', 12)
('38', 6)
('thirty', 2)
('33', 8)
('32', 10)
('study', 32)
('30', 31)
('37', 6)
('36', 8)
('35', 19)
('34', 12)
('gene', 35)
('changes', 2)
('diameter', 2)
('useful', 1)
('family', 4)
('invasive breast carcinomas', 4)
('ninety', 4)
('decrease', 22)
('marker', 8)
('total', 5)
('g\\/ml', 4)
('positive', 74)
('abbreviations', 2)
('faint', 2)
('negative', 32)
('few', 4)
('6', 289)
('actin', 2)
('type', 8)
('0\\%', 28)
('1\\.1\\-2\\.0', 2)
('lymphovascular', 11)
('biotin', 6)
('rabbit', 4)
('particular', 2)
('cases', 4)
('ml', 6)
('modified', 3)
('tissue', 29)
('values', 4)
('metastases', 4)
('cell nucleus', 2)
('10\\%', 6)
('control', 15)
('sps', 4)
('12\\.0', 2)
('cancer center', 4)
('high', 9)
('association', 44)
('serum', 16)
('dialysis', 2)
('discussion', 2)
('six', 4)
('feature', 6)
('1', 475)
('methanol', 2)
('significance', 4)
('goat', 6)
('30 min', 2)
('profile', 2)
('blocks', 2)
('prognostic', 4)
('transforming', 2)
('clone', 2)
('signature', 2)
('eighty', 2)
('tumor recurrence', 2)
('invasion', 13)
('data', 16)
('short', 4)
('biomarker', 1)
('guanine nucleotide exchange factor', 5)
('univariate analysis', 8)
('mastectomy', 3)
('retrieval', 5)
('stains', 4)
('preclinical', 2)
('primary tumors', 2)
('report', 8)
('staining', 56)
('24', 11)
('25', 13)
('26', 22)
('27', 6)
('20', 40)
('21', 18)
('22', 6)
('23', 17)
('alternative therapies', 2)
('29', 12)
('edge', 6)
('better', 2)
('window', 2)
('no\\.', 2)
('fig', 20)
('decreased', 19)
('texas', 2)
('5\\.0', 4)
('ym', 27)
('greater', 3)
('signaling pathway', 6)
('number', 6)
('lymph node metastases', 4)
('hormone receptor', 11)
('net1', 124)
('histologic type', 4)
('several', 2)
('university', 2)
('l-', 8)
('proteins', 4)
('pathway', 8)
('bursts', 2)
('mrna', 2)
('tumors', 19)
('mean', 8)
('subset', 5)
('protein a-sepharose', 2)
('conflicting', 2)
('generation', 2)
('her2\\.', 2)
('bovine', 4)
('year', 17)
('methotrexate', 6)
('laboratory', 2)
('81', 2)
('array', 13)
('er', 527)
('negative control', 8)
('breast tissue', 8)
('factors', 13)
('20\\%', 10)
('forty', 2)
('adhesion', 2)
('mediated', 5)
('7', 99)
('integrin\xe2\x80\x93rhoa', 6)
('induced', 1)
('evaluation', 4)
('signaling-deficient', 2)
('immunohistochemistry', 5)
('1\\+', 2)
('localization', 4)
('activity', 4)
('free', 30)
('standard', 4)
('labs', 6)
('difficulty', 4)
('biological', 2)
('rhoa', 24)
('log', 26)
('rearrangements', 2)
('cycles', 14)
('g', 652)
('filter', 2)
('leading', 2)
('first', 2)
('initial', 2)
('grade', 18)
('variables', 5)
('primary', 12)
('rank', 4)
('one', 49)
('randomized', 4)
('cytoskeletal', 4)
('human epidermal growth factor receptor', 3)
('background stain', 2)
('node-positive', 3)
('ten', 4)
('lymph nodes', 8)
('introduction', 1)
('unknown', 4)
('top', 32)
('plastic', 2)
('1a', 2)
('1b', 2)
('motility', 4)
('inclusion criteria', 2)
('chemotherapy', 6)
('white', 2)
('final', 2)
('integrins', 2)
('alone\\.', 7)
('slides', 4)
('part', 6)
('signaling', 18)
('authors', 2)
('percentage', 2)
('population', 2)
('11', 11)
('10', 41)
('13', 11)
('12', 19)
('15', 20)
('14', 17)
('17', 5)
('16', 13)
('19', 14)
('was', 138)
('patients', 84)
('individual', 7)
('outcome', 19)
('migration', 5)
('pre', 174)
('myoepithelial cell', 8)
('cytoplasm', 30)
('vinblastine', 6)
('rat', 49)
('30\\%', 2)
('ras', 7)
('concentration', 4)
('l\\/ml', 2)
('polyclonal', 2)
('-', 172)
('m\\.d\\.', 4)
('mechanism', 2)
('room temperature', 6)
('resectable', 2)
('forces', 2)
('objective', 2)
('peroxidase', 6)
('criteria', 6)
('multiple', 7)
('normal', 14)
('carcinoma', 23)
('significant', 19)
('70', 8)
('future', 2)
('nucleotide', 5)
('basal', 10)
('gtpases', 1)
('average', 4)
('protein expression', 2)
('disease', 5)
('20-35', 2)
('subgroup', 4)
('invasive breast carcinoma', 10)
('expression\\.', 6)
('aggressive', 1)
('papillary', 2)
('ssps', 2)
('heterodimer', 1)
('current', 4)
('indicator', 2)
('based', 8)
('knowledge', 4)
('retrospective study', 6)
('proportion', 6)
('state', 3)
('terminal', 2)
('only', 21)
('black', 2)
('factor', 23)
('8', 91)
('\\/ml', 6)
('normal breast', 10)
('epidermal', 3)
('mixture', 2)
('metastasis\\.', 8)
('overall', 27)
('ssp', 2)
('greater than', 2)
('axillary lymph node', 2)
('breast', 53)
('bead', 2)
('2', 365)
('years', 7)
('secondary', 4)
('distant metastasis', 36)
('beads', 2)
('peroxidase activity', 2)
('antihuman', 2)
('median', 1)
('subtype', 4)
('18', 10)
('fixed', 1)
('rhoa-specific', 3)
('in vitro', 2)
('irradiation', 2)
('set', 13)
('aspect', 4)
('immunoperoxidase', 2)
('detection', 2)
('cytoplasmic', 28)
('result', 15)
('estrogen receptor', 20)
('surgery', 2)
('nuclear', 22)
('3', 241)
('score', 10)
('therapies', 8)
('available', 4)
('high risk', 3)
('ability', 3)
('targeted', 4)
('weak', 2)
('fig\\.', 12)
('hypothesis', 6)
('windows', 2)
('group', 13)
('h2o2', 2)
('anti-net1', 4)
('improved', 2)
('3\\+', 10)
('many', 5)
('patient outcome', 4)
('heating', 2)
('expression', 125)
('traction', 4)
('cancer', 33)
('tumor cell migration', 4)
('reasons', 2)
('invasive', 30)
('period', 2)
('avidin-biotin', 2)
('64', 4)
('65', 4)
('66', 2)
('sequences', 2)
('table', 18)
('amino', 4)
('pr', 249)
('progesterone receptor', 8)
('addition', 6)
('three', 2)
('lobular', 8)
('lu', 85)
('integrin', 62)
('gene transcription', 2)
('monoclonal', 2)
('treatment', 6)
('sufficient', 6)
('present', 6)
('4-9', 2)
('value', 6)
('1 h', 10)
('51-70', 2)
('2\\+', 10)
('inverse association', 2)
('formalin', 1)
('layer', 8)
('membranous', 10)
('characteristics', 2)
('eighteen', 2)
('tumor cell', 20)
('triple', 6)
('tumorigenesis', 4)
('protein', 13)
('regression', 6)
('cohort', 10)
('radiation', 3)
('member', 3)
('microarray', 11)
('trastuzamab', 2)
('patient', 100)
('9', 131)
('subunit', 15)
('higher', 2)
('development', 5)
('independent', 13)
('total mastectomy', 1)
('1-3', 6)
('1-2', 2)
('kit', 2)
('immunohistochemical', 12)
('net1\\.', 8)
('recent', 3)
('antibodies', 2)
('center', 4)
('surrogate', 2)
('studies', 4)
('analysis', 35)
('hispanic', 8)
('materials', 1)
('entry', 2)
('model', 8)
('usual', 2)
('citrate buffer', 4)
('c-terminal', 2)
('abbreviation', 4)
('50\\%', 2)
('intervals', 2)
('distant', 38)
('breast cancers', 12)
('human', 5)
('purified', 4)
('myoepithelial', 10)
('previous', 4)
('tables', 2)
('\\>', 10)
('\\?', 407)
('\\:', 10)
('guanine', 5)
('4', 344)
('\\.', 492)
('5', 184)
('\\,', 330)
('\\*', 20)
('\\(', 198)
('\\)', 198)
('associations', 7)
('bovine serum albumin', 4)
('race', 10)
('increased', 4)
('2\\.1\\-3\\.0', 2)
('survival', 52)
('early', 4)
('finding', 5)
('ducts', 2)
('background', 6)
('axillary', 6)
('outcome measure', 2)
('ductal', 12)
('55', 12)
('54', 2)
('signal', 21)
('56', 4)
('51', 4)
('50', 8)
('52', 4)
('specific', 6)
('benefit', 2)
('either', 3)
('dilution', 2)
('transforming gene', 2)
('satisfactory', 2)
('methods', 1)
('luminal', 4)
('manual', 2)
('kda', 2)
('growth', 5)
('export', 4)
('69', 2)
('subtypes', 2)
('invasive lobular carcinoma', 4)
('ductal epithelium', 2)
('invasive lobular carcinomas', 2)
('microwave', 4)
('71', 4)
('moderate', 4)
('gene expression', 4)
('bd', 2)
('core', 20)
('data analysis', 2)
('surgical treatment', 2)
('power', 2)
('axillary dissection', 4)
('histologic', 4)
('pressure', 2)
('step', 2)
('glycerol', 4)
('post', 2)
('column', 2)
('months', 4)
('statistically significant', 2)
('positive lymph node', 6)
('spss', 2)
('tumor', 80)
('range', 12)
('plus', 6)
('mixed', 2)
('insufficient', 4)
('neuroepithelioma', 2)
('antibody', 10)
('block', 4)
('rho', 25)
('presence', 2)
('instruments', 2)
('preliminary', 2)
('cyclophosphamide', 8)
('functional', 2)
('two', 10)
('receptor', 43)
('surrogate marker', 2)
('multivariate analysis', 13)
('additional', 4)
('sequence', 2)
('long', 3)
('immunohistochemical stains', 4)
('4\\.1\\-5\\.0', 2)
('clinical', 18)
('low', 16)
('series', 2)
('albumin', 4)
('breast cancer', 25)
('function', 4)
('70\\%', 4)
('menopausal', 2)
('lymph', 25)
('mice', 6)
('absent', 6)
('terminus', 2)
('3\\.1\\-4\\.0', 2)
('cells', 20)
('doxorubicin', 14)
('cancers', 16)
('mouse model', 2)
('problem', 2)
('similar', 2)
('breast ducts', 2)
('molecular profiling', 2)
('estrogen', 20)
('regression analysis', 2)
('receptor expression', 2)
('tissues', 3)
('metastasis', 40)
('al', 434)
('single', 2)
('epithelial', 13)
('follow-up', 4)
('ductal epithelial cell', 2)
('functions', 1)
('48', 14)
('47', 10)
('42', 8)
('43', 4)
('40', 12)
('41', 8)
('invasive growth', 2)
('other', 12)
('role', 6)
('cell adhesion', 2)
('node', 19)
('meaning', 2)
('important', 16)
('nucleus', 6)
('avidin', 2)
('variable', 11)
('homolog', 3)
('hazard ratio', 12)
('cooker', 2)
('exact test', 4)
('age', 24)
('acids', 2)
('curve', 4)
('diagnosis', 4)
('n1', 2)
('n2', 2)
('original', 2)
